Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Reuters NewMedia - May 7, 2009
Barry Malone
* Economies would benefit
ADDIS ABABA (Reuters) - Africa must manufacture its own generic medicine if it is to continue to fight HIV/AIDS during the financial crisis and ensure its faltering economies can benefit from drug production, the African Union (AU) says.
"Africa shouldn't just import drugs all the time," AU Commissioner for Social Affairs, Bience Gawanas, told Reuters on the sidelines of a conference of African ministers for health in Ethiopian capital Addis Ababa.
"Most of our HIV/AIDS drugs come from sources outside Africa. How can we be sure this will continue during the financial crisis?"
South Africa is the only African country that makes its own HIV/AIDS drugs
Michel Sidibe, the new head of the United Nations HIV/AIDS agency and the first African to hold the position, has said ensuring all Africans who suffer from the virus have access to drugs will be his priority.
Most infected Africans have no access to treatment, though a few countries were doing exceptionally well, Gawanas said.
"Some countries in Africa now have 80 percent of people with HIV/AIDS on anti-retroviral drugs," Gawanas said. "But if there are cuts (in support from donor countries) can that progress continue? We need to mobilize local production."
African economies would profit from the drugs being made locally, Gawanas said.
An estimated 33 million people globally are infected with the HIV virus that causes AIDS, and most of them live in Africa and other developing countries.
090507
RE090503
Copyright © 2009 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .